Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-24-025291
Filing Date
2024-10-07
Accepted
2024-10-07 16:58:38
Documents
1
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 5829
  Complete submission text file 0001127602-24-025291.txt   7557
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, FLOOR 37 NEW YORK NY 10001
Business Address
DeFrancesco Lisa (Reporting) CIK: 0001846325 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30111 | Film No.: 241358411